Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV000408599 | SCV000281957 | likely pathogenic | Severe early-childhood-onset retinal dystrophy | 2016-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001055307 | SCV001219694 | pathogenic | not provided | 2024-03-14 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 2109 of the ABCA4 protein (p.Leu2109Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with ABCA4-related retinal dystrophy (PMID: 28118664, 29555955). ClinVar contains an entry for this variant (Variation ID: 236147). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV004816433 | SCV005072404 | likely pathogenic | Retinal dystrophy | 2019-01-01 | criteria provided, single submitter | clinical testing |